Pfizer Global Supply president Maddaluna to retire

NEW YORK — Anthony Maddaluna, Pfizer EVP, president of Pfizer Global Supply and a 41-year company veteran will be retiring, Pfizer announced Monday. Maddaluna will be succeeded by Kirsten Lund-Jurgensen, effective Dec. 30. 

 

“I have had the privilege of working with Tony during much of his career, and he has been a valuable partner to me,” Pfizer chairman and CEO Ian Read said. “Tony has continually demonstrated a steadfast commitment to Pfizer and our mission. His focus on quality, compliance and customer service has established Pfizer Global Supply as an industry leading supply organization that is highly respected by internal and external stakeholders. I know I join all Pfizer colleagues in thanking Tony for his tireless efforts and wishing him and his family all the best as 

 

Maddaluna began working at Pfizer in 1975 and has held several positions with increasing responsibilities since then, eventually being named president of Pfizer Global Supply in 2011. 

 

“I have thoroughly enjoyed my career at Pfizer and being part of the company’s executive leadership team,” Maddaluna said. “Based on more than four decades at Pfizer, I am truly proud of our dedicated colleagues who have discovered, developed and delivered the high quality vaccines and medicines that combat the world’s most pressing healthcare challenges today.”

 

Lund-Jurgensen joined Pfizer in 1999 as VP global supply chain management, pharmaceuticals. Prior to that she was with SmithKline Beecham in Germany, Australia and the United States, serving in various operational roles. She is a pharmacist with a Ph. D. in pharmaceutical biology from Germany’s Freiburg University.